<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Abstract Background: The aim of this study was to determine the ability of glycated <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> (GHb) to predict <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> in an Iranian population with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (NGT) </plain></SENT>
<SENT sid="1" pm="."><plain>Methods: A cross-sectional study of first-degree relatives (FDRs) of patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> was conducted from 2003 to 2005 </plain></SENT>
<SENT sid="2" pm="."><plain>A total of 1386 FDRs of consecutive patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> 30-60 years old (355 men and 1031 women) with NGT were examined </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> subjects underwent a standard 75-gram 2-h oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test and GHb measurement </plain></SENT>
<SENT sid="4" pm="."><plain>Consensus criteria in 2009 were used to identify <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Unadjusted and adjusted multivariate logistic regression analysis was performed to assess the risk of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The mean [standard deviation (SD)] age of participants was 42.4 (6.3) years </plain></SENT>
<SENT sid="7" pm="."><plain>Results: The prevalence of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> was 17.5% in men and 21.5% in women </plain></SENT>
<SENT sid="8" pm="."><plain>The multivariate-adjusted odds ratio (95% CI) of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> was 2.01 (1.03, 3.93) for the highest quintile of GHb compared with lowest quintile </plain></SENT>
<SENT sid="9" pm="."><plain>These data indicate that GHb was associated with <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, independently of gender among FDRs of patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> with NGT </plain></SENT>
<SENT sid="10" pm="."><plain>Conclusions: These data indicate that GHb below the level for <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> might be a predictive measure of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> in FDRs of patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> with NGT </plain></SENT>
</text></document>